Free radical pathology in schizophrenia: a review (Q41185166)

28 September 2017

1 reference

title

Free radical pathology in schizophrenia: a review (English)

1 reference

28 September 2017

0 references

Reddy RD

1

1 reference

28 September 2017

Yao JK

series ordinal

2

1 reference

28 September 2017

publication date

1 August 1996

1 reference

Prostaglandins, Leukotrienes and Essential Fatty Acids

28 September 2017

published in

1 reference

28 September 2017

volume

55

1 reference

28 September 2017

issue

1-2

1 reference

28 September 2017

page(s)

33-43

1 reference

Reactive oxygen species and the central nervous system

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Polyunsaturated fatty acids, prostaglandins, and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Enzymatic/nonenzymatic sources of oxyradicals and regulation of antioxidant defenses.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Reactive Oxygen Species on GABA Releasea

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Peroxidation induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Regulation of gamma-aminobutyric acid/barbiturate receptor-gated chloride ion flux in brain vesicles by phospholipase A2: possible role of oxygen radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Electrophysiological correlates of peroxide damage in guinea pig hippocampus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Arachidonic Acid: A Common Link in the Biology of Schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Neurochemistry and neuroendocrinology of schizophrenia: a selective review

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Phospholipid Methylation and Biological Signal Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

On the physical properties of red cell ghost membranes in the affective disorders and psychoses. A fluorescence polarization study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Reduced temporal lobe areas in schizophrenia: preliminary evidences from a controlled multiplanar magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Schizophrenia; a new approach. II. Result of a year's research

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Relationship between antioxidants, prooxidants, and the aging process

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Increased pentane and carbon disulfide in the breath of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Electron microscopic study on schizophrenia. Mechanism of pathological changes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Structural lesions of the brain in young schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Schizophrenia: a neuropathological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Vitamin C status in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Glutathione peroxidase and CT scan abnormalities in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Effects of chlorpromazine on the activities of antioxidant enzymes and lipid peroxidation in the various regions of aging rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Free radical scavenging enzyme activity and related trace metals in clozapine-induced agranulocytosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Vitamin E as an in vitro and in vivo antioxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Vitamin E treatment of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Effectiveness of vitamin E for treatment of long-term tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Treatment of tardive dyskinesia with vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Vitamin E in the treatment of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Alpha-tocopherol in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Vitamin E in the treatment of tardive dyskinesia: a replication study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Metabolism of Oxygen Derivatives in Down's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Trisomy 21 (Down's Syndrome) glutathione peroxidase, hexose monophosphate shunt and I.Q

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Demential syndromes and the lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Free radicals in the genesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Brain Peroxidase and Catalase in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Distribution of arsenic, manganese, and selenium in the human brain in chronic renal insufficiency, Parkinson's disease, and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Glutathione peroxidase activity in Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Oxygen toxicity protecting enzymes in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

Regional neuropathology in schizophrenia: where are we? Where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990143-X

7 January 2021

10.1016/S0952-3278(96)90143-X

Identifiers

DOI

1 reference

28 September 2017

1 reference